Global Vision, the industry leader in the development of automated proofreading solutions, today announced the release of its new custom wet ink roll scanner (Scan Wet-ink™) for digital scanning of packaging components.
Global Vision, the industry leader in the development of automated proofreading solutions, today announced the launch of the StandardPractice™ the industries first set of guidelines outlining the issues, risks, solutions and tools involved in the creation of digital files.
Persistent Systems, the global leader in software product and technology services today announced that the company will showcase its market leading Paxpro Design to Print (D2P) Automation Solutions for regulated industries, integrated with Global Vision’s suite of automated proofreading solutions. The integrated offering is being showcased at the Pharma Packaging and Labeling USA 2013 conference being held February 26 and 27 at the Hilton Philadelphia City Avenue Hotel.
Woodley Equipment Company Ltd is a leading specialist global supplier and service provider to the Clinical Trials industry. Woodley have been providing equipment solutions to the industry for over 20 years and is the supplier of choice to many of the largest companies in Clinical Research, as well as partner to small and medium sized companies around the World.
Woodley Equipment is one of the leading specialist medical and laboratory equipment suppliers to the Clinical Trials Industry and has been providing Centrifuges for rental and sale for over 20 years. Woodley is the supplier of choice to many of the largest companies in Clinical Research, as well as partner of small and medium sized companies around the World.
Dec Group, with headquarters in Lausanne, Switzerland is pleased to announce its forthcoming attendance at Powtech 2013, international trade fair taking place in Nuremberg, Germany from April 23 – 25, 2013.
ChromoTek has announced today the signing of a license agreement granting Bayer Pharma AG (Bayer) the right to use ChromoTek's proprietary Cell Cycle Chromobody® Technology for drug profiling by High Content Analysis.
ChromoTek GmbH offers nanobody based real time assays to visualize and measure the action of candidate drugs or other substances of interest on important regulatory processes in living cells. Presently, four Chromobody ® plasmids are available for analyzing the cell cycle, apoptosis, DNA methylation and cytoskeleton dynamics.
reMYND NV announced today that Bernd Bohrmann (Neuroscience, Roche) is presenting preclinical efficacy data at the leading AD/PD conference held March 6th-10th in Florence, on a novel combination therapy tested in an Alzheimer mouse model in collaboration with reMYND's Contract Research Organization (CRO).
This year, the EU Regulation on cosmetic products (Regulation 1223/2009) introduces new requirements related to safety of the cosmetic products as well as new registration procedures.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.